Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 0.808

-0.9%

Feb 2 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: stock_hound	3/10/2006 12:06:39 PM
	Read Replies (1) of 14328

TRIB announces they are going to apply for FDA approval of OTC HIV test. Stock is undervalued based on competitors (comparable fundamentals to OSUR which has market cap 3X TRIB)Stock is moving up and gaining momentum. "Trinity Biotech plc (NasdaqNM:TRIB - News) (ISE: TRIB.I), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it has written to the United States Food and Drug Administration (FDA) requesting a meeting to discuss the conditions under which the FDA might grant marketing clearance for Over The Counter (OTC) sale of the company's UniGold HIV test. In addition Trinity will present at a meeting of the Blood Products Advisory Committee (BPAC) of the FDA in Washington tomorrow Friday 10th March 2006 and will present its position on home testing for HIV."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next